Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 5, 2008, Pages 619-625

  Bertrand, Oliver F ^a   Rodés Cabau, Josep ^a   Larose, Éric ^a   Proulx, Guy ^a   Gleeton, Onil ^a   Nguyen, Can Manh ^a   Nault, Isabelle ^a   Roy, Louis ^a   Poirier, Paul ^a   Casterousse, Oliver ^a   De Larochellière, Robert ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Acute coronary syndrome; Complications adult cath intervention; Percutaneous coronary intervention; Thrombosis; Transradial cath

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; ANTITHROMBOCYTIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DISSECTION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY STENT; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ACUTE CORONARY SYNDROME; AGED; COMPARATIVE STUDY; HOSPITAL DISCHARGE; INSTRUMENTATION; LENGTH OF STAY; MIDDLE AGED; MORTALITY; PATIENT CARE; PATIENT SELECTION; RADIAL ARTERY; RADIOGRAPHY; RISK ASSESSMENT; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NIGHT CARE; PATIENT DISCHARGE; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; RADIAL ARTERY; RISK ASSESSMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 57149100040     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21662     Document Type: Article

References (25)

1. Bertrand OF, De Larochelliere R, Rodes-Cabau J, Proulx G, Gleeton O, Nguyen CM, Dery JP, Barbeau G, Noel B, Larose E, et al. A randomized study comparing sameday home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation. Circulation 2006;114:2636-2643.
2. Bertrand OF, Rodes-Cabau J, Larose E, Nguyen CM, Roy L, Dery JP, Courtis J, Nault I, Poirier P, Costerousse O, et al. One-year clinical outcomes after abciximab bolus-only compared to abciximab bolus and 12-hour infusion in the randomized early discharge after transradial stenting of coronary arteries (EASY) study. Am Heart J 2008.
3. Bertrand OF, Larose E, De Larochelliere R, Proulx G, Nguyen CM, Dery JP, Gleeton O, Barbeau G, Noel B, Rouleau J, et al. Outpatient percutaneous coronary intervention: Ready for prime time? Can J Cardiol 2007;23:58B-66B.
4. Mangin L, Bertrand OF, De La Rochelliere R, Proulx G, Lemay R, Barbeau G, Gleeton O, Rodes-Cabau J, Nguyen CM, Roy L. The transulnar approach for coronary intervention: A safe alternative to transradial approach in selected patients. J Invas Cardiol 2005;17:77-79.
5. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863.
6. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harrington RA, Krumholz HM, Simoons ML, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-2130.
7. Heyde GS, Koch KT, de Winter RJ, Dijkgraaf MG, Klees MI, Dijksman LM, Piek JJ, Tijssen JG. Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: Results of the Elective PCI in Outpatient Study (EPOS). Circulation 2007;115:2299-2306.
8. Kiemeneij F, Laarman GJ, Slagboom T, van der Wieken R. Outpatient coronary stent implantation. J Am Coll Cardiol 1997;29: 323-327.
9. Slagboom T, Kiemeneij F, Laarman GJ, van der Wieken R. Outpatient coronary angioplasty: Feasible and safe. Catheter Cardiovasc Interv 2005;64:421-427.
10. Anderson KM, Califf RM, Stone GW, Neumann FJ, Montalescot G, Miller DP, Ferguson JJ III, Willerson JT, Weisman HF, Topol EJ. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2001;37:2059-2065.
11. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 2004;292:696-703.
12. Mukherjee D, Topol EJ, Bertrand ME, Kristensen SD, Herrmann HC, Neumann FJ, Yakubov SJ, Bassand JP, McClure RR, Stone GW, et al. Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: Do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. Eur Heart J 2005;26:2524-2528.
13. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY Trial. J Am Coll Cardiol 2007;49:1362-1368.
14. Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 2007;369:907-919.
15. Kiemeneij F, Laarman GJ, Slagboom T, Stella P. Transradial palmaz-schatz coronary stenting on an outpatient basis: Results of a prospective pilot study. J Invas Cardiol 1995;7:5A-11A.
16. Koch KT, Piek JJ, Prins MH, de Winter RJ, Mulder K, Lie KI, Tijssen JG. Triage of patients for short term observation after elective coronary angioplasty. Heart 2000;83:557-563.
17. Slagboom T, Kiemeneij F, Laarman GJ, van der Wieken R, Odekerken D. Actual outpatient PTCA: Results of the OUTCLAS pilot study. Catheter Cardiovasc Interv 2001;53:204-208.
18. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Chauhan MS, Rodriguez O, Kuntz RE. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-1971.
19. Antoniucci D, Valenti R, Santoro GM, Bolognese L, Trapani M, Fazzini PF. Preliminary experience with stent-supported coronary angioplasty in long narrowings using the long freedom force stent: Acute and six-month clinical and angiographic results in a series of 27 consecutive patients. Cathet Cardiovasc Diagn 1998;43:163-167.
20. Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, Canos D, Castagna M, Weissman NJ, Waksman R. Predictors of subacute stent thrombosis: Results of a systematic intravascular ultrasound study. Circulation 2003;108:43-47.
21. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, Di Mario C, Colombo A. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-659.
22. Kornowski R, Bhargava B, Fuchs S, Lansky AJ, Satler LF, Pichard AD, Hong MK, Kent KM, Mehran R, Stone GW, et al. Procedural results and late clinical outcomes after percutaneous interventions using long (> or = 25 mm) versus short (<20 mm) stents. J Am Coll Cardiol 2000; 35:612-618.
23. Le Breton H, Bedossa M, Commeau P, Boschat J, Huret B, Gilard M, Brunel P, Crochet D, Grollier G, Douillet R, et al. Clinical and angiographic results of stenting for long coronary arterial atherosclerotic lesions. Am J Cardiol 1998;82:1539-1543.
24. Alfonso F, Hernandez R, Goicolea J, Segovia J, Perez-Vizcayno MJ, Banuelos C, Silva JC, Zarco P, Macaya C. Coronary stenting for acute coronary dissection after coronary angioplasty: Implications of residual dissection. J Am Coll Cardiol 1994;24: 989-995.
25. Biondi-Zoccai GG, Agostoni P, Sangiorgi GM, Airoldi F, Cosgrave J, Chieffo A, Barbagallo R, Tamburino C, Vittori G, Falchetti E, et al. Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation. Eur Heart J 2006;27:540-546.